For last week’s practice question, we quizzed participants on Lower Extremity Recommendation for JT? . 77% of respondents chose the best answer. We want to clarify and share this important information, … Continue reading Rationale of the Week | Lower Extremity Recommendation for JT?
Featured Articles _________________________ Overcoming Defeat & Looking Fear in the Face Carb Counting in the AI Era Beta Bionics – Celebrate Freedom from Carb Counts New! Scholarships for San Diego … Continue reading August 2025 eNews
By: Sarah Beattie, DNP, APRN-CNP, CDCES C.K. is a 55-year-old elementary school teacher diagnosed with type 1 diabetes ten years ago and is managing glycemic control with multiple daily injections … Continue reading Question of the Week | Insulin Pump Inquiry for Rising A1C on MDI?
Level 4 | 3 Steps to DeFeet Amputation – Join us live on August 12th for the 2025 update! Coach Beverly will walk participants through the 3-Step Process to Save … Continue reading Upcoming Webinars for August!
For last week’s practice question, we quizzed participants on Best example of Person-Centered Question. 93% of respondents chose the best answer – GREAT JOB! We want to clarify and share this … Continue reading Rationale of the Week | Best example of Person-Centered Question?
By: Christine Craig, MS, RD, CDCES Summer offers an excellent opportunity to engage with fresh, seasonal eating and a local farmer’s market offers an ideal starting point for both inspiration … Continue reading Strategies to Bridge Gaps in Diabetes Nutrition
JT is a 58-year-old with type 2 diabetes presents for a routine exam. Has a 20-year history of diabetes, hypertension, and peripheral neuropathy. Reports no foot pain, but partner … Continue reading Question of the Week | Lower Extremity Recommendation for JT?
For last week’s practice question, we quizzed participants on What best describes the action of GLP-1 Receptor Agonists? 54% of respondents chose the best answer. We want to clarify and … Continue reading Rationale of the Week | What best describes the action of GLP-1 Receptor Agonists?